Get the Stockscreener App
18.45
1.18%
-0.22
Pre-market:
18.09
-0.36
-1.95%
Ceribell Inc stock is traded at $18.45, with a volume of 179.45K.
It is down -1.18% in the last 24 hours and down -4.16% over the past month.
CeriBell Inc is a medical technology company focused on transforming the diagnosis and management of patients with serious neurological conditions. The company has developed the Ceribell System, a novel, point-of-care electroencephalography (EEG) platform designed to address the unmet needs of patients in the acute care setting. By combining proprietary, portable, and rapidly deployable hardware with sophisticated artificial intelligence (AI)-powered algorithms, the Ceribell System enables rapid diagnosis and continuous monitoring of patients with neurological conditions. Its products are Point-of-Care EEG, Clarity, and EEG Portal.
See More
Previous Close:
$18.67
Open:
$18.81
24h Volume:
179.45K
Relative Volume:
0.59
Market Cap:
$700.04M
Revenue:
$89.06M
Net Income/Loss:
$-53.41M
P/E Ratio:
-12.63
EPS:
-1.4612
Net Cash Flow:
$-42.48M
1W Performance:
-1.70%
1M Performance:
-4.16%
6M Performance:
+8.72%
1Y Performance:
+8.40%
1-Day Range:
$18.42
$18.99
1-Week Range:
$18.42
$19.13
52-Week Range:
$10.85
$24.33
Ceribell Inc Stock (CBLL) Company Profile
Name
Ceribell Inc
Sector
Industry
Phone
(800) 436-0826
Address
360 N. PASTORIA AVENUE, SUNNYVALE
Compare CBLL vs ABT, SYK, MDT, BSX, EW
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
CBLL
Ceribell Inc
|
18.45 | 708.39M | 89.06M | -53.41M | -42.48M | -1.4612 |
ABT
Abbott Laboratories
|
85.60 | 150.32B | 45.13B | 6.28B | 7.38B | 3.5895 |
SYK
Stryker Corp
|
305.09 | 117.93B | 25.27B | 3.34B | 4.57B | 8.6334 |
MDT
Medtronic Plc
|
73.81 | 97.02B | 35.48B | 4.64B | 5.41B | 3.582 |
BSX
Boston Scientific Corp
|
48.31 | 72.99B | 20.62B | 3.56B | 3.48B | 2.3847 |
EW
Edwards Lifesciences Corp
|
86.47 | 49.50B | 6.30B | 1.07B | 1.09B | 1.8406 |
Ceribell Inc Stock (CBLL) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Oct-21-25 | Initiated | Raymond James | Strong Buy |
| Jun-24-25 | Initiated | BTIG Research | Buy |
| Apr-04-25 | Initiated | Ladenburg Thalmann | Buy |
| Nov-05-24 | Initiated | BofA Securities | Buy |
| Nov-05-24 | Initiated | Canaccord Genuity | Buy |
| Nov-05-24 | Initiated | JP Morgan | Overweight |
| Nov-05-24 | Initiated | TD Cowen | Buy |
| Nov-05-24 | Initiated | William Blair | Outperform |
View All
Ceribell Inc Stock (CBLL) Latest News
InvestingPro’s Fair Value warned of CeriBell crash 17 months ago By Investing.com - Investing.com
CeriBell (CBLL) Earnings Date and Reports 2026 $CBLL - MarketBeat
Ceribell Leadership Unloads Shares in a Wave of Insider Stock Moves - TipRanks
Ceribell CEO to present at William Blair Growth Stock Conference on June 3, 2026 - Pluang
Ceribell to Participate in the William Blair 46th Annual Growth Stock Conference - GlobeNewswire
Earnings call transcript: Ceribell Inc. Q1 2026 misses EPS, revenue up - Investing.com Nigeria
Bank of America Securities Remains a Buy on Ceribell, Inc. (CBLL) - The Globe and Mail
Canaccord Genuity maintains Ceribell (CBLL) buy recommendation - MSN
Ceribell anticipates $112M-$116M 2026 revenue while targeting delirium NTAP of up to $2,171 per patient - MSN
CeriBell Sees ‘Early Innings’ Growth as Hospital Accounts and Usage Hit Records - Yahoo Finance
Ladenburg Thalmann Maintains Ceribell(CBLL.US) With Buy Rating, Maintains Target Price $32 - Moomoo
Middle East Tensions Threaten Ceribell’s Supply Chain, Shipping Routes, and Margins - TipRanks
Ceribell’s Earnings Call Signals Growth Over Profits - The Globe and Mail
TD Cowen Maintains Ceribell(CBLL.US) With Buy Rating, Maintains Target Price $29 - Moomoo
A Quick Look at Today's Ratings for Ceribell(CBLL.US), With a Forecast Between $25 to $29 - Moomoo
Canaccord lowers Ceribell stock price target on valuation compression By Investing.com - Investing.com Australia
Canaccord lowers Ceribell stock price target on valuation compression - Investing.com
Ceribell: Buy Rating Reiterated on Strong Q1 Momentum and Expanded TAM, $28 Price Target Maintained - TipRanks
Ceribell Reports First Quarter 2026 Financial Results - The Manila Times
Ceribell, Inc. (CBLL) reports Q1 loss, beats revenue estimates - MSN
CeriBell Q1 Earnings Call Highlights - inkl
CeriBell (CBLL) Q1 2026 Earnings Transcript - AOL.com
CeriBell, Inc. (CBLL) Reports Q1 Loss, Beats Revenue Estimates - Yahoo Finance
CeriBell Q1 Loss Widens, Revenue Rises; Lifts Full-Year Revenue Guidance - Moomoo
Ceribell Inc (NASDAQ:CBLL) Q1 Revenue Beats Estimates, Net Loss Widens, Full-Year Guidance Raised - ChartMill
CERIBELL ($CBLL) Releases Q1 2026 Earnings - Quiver Quantitative
Ceribell beats Q1 revenue estimates; lifts 2026 guidance - TradingView
(CBLL) CeriBell Now Expects 2026 Revenue Range $112M-$116M, vs. FactSet Est of $113.1M - marketscreener.com
Earnings Flash (CBLL) CeriBell Posts Q1 Per Share Loss $0.52, vs. FactSet Est of Loss $0.39 - marketscreener.com
Earnings Flash (CBLL) Ceribell, Inc. Reports Q1 Revenue $26.5M, vs. FactSet Est of $26.1M - marketscreener.com
Ceribell, Inc. Raises Revenue Guidance for the Full Year 2026 - marketscreener.com
Number of shareholders of CeriBell, Inc. – NASDAQ:CBLL - TradingView
[144] Ceribell, Inc. SEC Filing - Stock Titan
Ceribell CEO Chao Xingjuan sells $783,973 in stock By Investing.com - Investing.com South Africa
Ceribell CEO Chao Xingjuan sells $783,973 in stock - Investing.com India
Ceribell (NASDAQ: CBLL) CEO sells 39,000 shares after options exercise - Stock Titan
FMR LLC holds 4.85M CERIBELL shares (CBLL) — Amendment No.3 - Stock Titan
Earnings Preview: Ceribell to Report Financial Results Post-market on May 11 - Moomoo
Insider sells 78,000 CBLL shares and 2,084 more (CBLL) - Stock Titan
Ceribell CTO Raymond Woo sells $226,928 of CBLL common stock - Investing.com India
Ceribell CTO Raymond Woo sells $226,928 of CBLL common stock By Investing.com - Investing.com South Africa
Ceribell (NASDAQ: CBLL) CTO sells shares under 10b5-1 trading plan - Stock Titan
Ceribell Inc Stock (CBLL) Financials Data
Revenue
Net Income
Cash Flow
EPS
0.59%
1.94%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):